Arch Venture Management’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-349,908
| Closed | -$152K | – | 9 |
|
|
2022
Q3 | $152K | Hold |
349,908
| – | – | 0.02% | 10 |
|
|
2022
Q2 | $298K | Hold |
349,908
| – | – | 0.04% | 9 |
|
|
2022
Q1 | $1.93M | Hold |
349,908
| – | – | 0.28% | 6 |
|
|
2021
Q4 | $3.39M | Buy |
+349,908
| New | +$3.39M | 0.36% | 6 |
|
|
2020
Q3 | $13.1M | Hold |
2,618,351
| – | – | 65.49% | 1 |
|
|
2020
Q2 | $15.7M | Hold |
2,618,351
| – | – | 52.68% | 1 |
|
|
2020
Q1 | $11.7M | Hold |
2,618,351
| – | – | 19.67% | 3 |
|
|
2019
Q4 | $24.9M | Hold |
2,618,351
| – | – | 32.42% | 1 |
|
|
2019
Q3 | $20.6M | Hold |
2,618,351
| – | – | 22.5% | 2 |
|
|
2019
Q2 | $41.2M | Hold |
2,618,351
| – | – | 42.64% | 1 |
|
|
2019
Q1 | $47.4M | Hold |
2,618,351
| – | – | 45.77% | 1 |
|
|
2018
Q4 | $42.1M | Buy |
+2,618,351
| New | +$42.1M | 42.09% | 1 |
|